Old Web
English
Sign In
Acemap
>
authorDetail
>
F. Caligaris Capio
F. Caligaris Capio
Homing (biology)
Medicine
Vascular-targeting agent
Cancer research
Pathology
3
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and anticancer activity of low dose regimen of NGRhTNF, a new vascular targeting agent, in solid advanced malignancies (NGR002 phase I trial)
2016
Journal of Clinical Oncology
Corrado Gallo Stampino
Gian-Paolo Rizzardi
Salvatore Toma
Angelo Corti
P. Scifo
Giovanni Citterio
Vanesa Gregorc
A. Del Maschio
F. Caligaris Capio
Claudio Bordignon
Show All
Source
Cite
Save
Citations (1)
Optimal safety profile and anticancer activity of NGRhTNF coupled with doxorubicin (NGR003 modified phase I combo trial)
2007
Journal of Clinical Oncology
Gian-Paolo Rizzardi
Vanesa Gregorc
Giordano Vitali
C. Gallo Stampino
C.M.L. van Herpen
Armando Santoro
A. Sobrero
Kees Punt
F. Caligaris Capio
Claudio Bordignon
Show All
Source
Cite
Save
Citations (0)
NGRhTNF, a new vascular targeting agent with a dual mechanism of action: preliminary clinical results
2006
Journal of Clinical Oncology
Claudio Bordignon
F. Caligaris Capio
Salvatore Toma
L. Manenti
P. Rizzardi
Flavio Curnis
C. Gallo-Stampino
A. Corti
Show All
Source
Cite
Save
Citations (2)
1